The CACNA2D2 protein encodes the alpha2delta-2 auxiliary subunit of voltage-gated calcium channels (VGCCs). This subunit plays a critical role in modulating calcium channel trafficking, function, and pharmacology in neurons. Mutations in CACNA2D2 cause autosomal recessive neurological disorders including epilepsy, cerebellar ataxia, and autism spectrum disorders.
:: infobox .infobox-protein
| CACNA2D2 Protein (Alpha2delta-2) |
|
| Gene |
CACNA2D2 |
| UniProt |
Q9YXG3 |
| Molecular Weight |
~130 kDa (precursor) |
| Subcellular Localization |
Plasma membrane |
| Protein Family |
Voltage-gated calcium channel auxiliary subunits |
| Aliases |
α2δ-2, CACNA2D2 |
===
The alpha2delta-2 protein is a unique auxiliary subunit with distinctive structural features:
- Alpha2 domain (N-terminal, ~1000 aa): Large extracellular domain containing multiple protein-protein interaction motifs, including a Von Willebrand factor type A domain (vWFA)
- Delta domain (C-terminal): Single transmembrane segment that anchors the protein to the plasma membrane
- Disulfide bonds: Covalent linkage between alpha2 and delta domains after proteolytic processing
The CACNA2D2 protein is synthesized as a single precursor that undergoes proteolytic cleavage to generate mature alpha2 and delta polypeptides that remain associated through disulfide bonds. This processing is essential for proper channel assembly and function.
The alpha2delta-2 subunit modulates voltage-gated calcium channel activity through multiple mechanisms:
- Trafficking promotion: Facilitates the transport of the main alpha1 subunit to the plasma membrane
- Current amplitude enhancement: Increases the magnitude of calcium currents
- Voltage dependence modification: Shifts activation/inactivation curves
- Kinetics alteration: Modifies activation and inactivation time constants
- Pharmacology modulation: Determines gabapentinoid sensitivity
Highest expression in:
- Cerebellum: Purkinje cells and granule cells
- Hippocampus: CA pyramidal neurons
- Cerebral cortex: Layer 2-3 neurons
- Spinal cord: Motor neurons
CACNA2D2 mutations cause autosomal recessive epilepsy syndromes:
- Early infantile epileptic encephalopathy 69 (EIEE69): Severe seizures with developmental regression
- Childhood absence epilepsy: Typical absence seizures
- Dravet syndrome-like phenotype: Febrile seizures progressing to refractory epilepsy
The mechanism involves impaired calcium channel trafficking leading to reduced synaptic vesicle release and altered neuronal excitability.
Progressive cerebellar dysfunction characterized by:
- Gait instability and limb ataxia
- Dysarthria and oculomotor abnormalities
- Intention tremor
- Delayed motor development
- Social and communication deficits
- Repetitive behaviors
- Intellectual disability (variable severity)
Potential involvement in AD pathophysiology:
- Altered calcium homeostasis in neurons
- Possible modulation of amyloid-beta effects on calcium signaling
- May influence synaptic function through presynaptic calcium regulation
- May affect dopaminergic neuron calcium handling
- Altered expression reported in PD models
- Potential role in regulating calcium-dependent dopamine release
| Approach |
Description |
Status |
| Gabapentinoids |
Bind to alpha2delta subunits (gabapentin, pregabalin) |
FDA approved for neuropathic pain |
| Small molecule enhancers |
Channel-specific modulators |
Research phase |
| Gene therapy |
AAV-mediated delivery |
Preclinical |
- Display ataxia and cerebellar dysfunction
- Show altered seizure susceptibility
- Impaired synaptic transmission at cerebellar synapses
- Recapitulate human disease phenotypes
- Used for drug testing and therapeutic development
The alpha2delta-2 subunit interacts with:
- Main VGCC alpha1 subunits: Cav2.1 (P/Q-type), Cav2.2 (N-type), Cav1.2 (L-type)
- Synaptic proteins: Syntaxin, SNAP-25
- caffold proteins: MAGUK family members